EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.11.17 | Abortion, Spontaneous |
32738170 |
CaMK4 Promotes Abortion-related Th17 Cell Imbalance by Activating AKT/mTOR Signaling Pathway. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.7.11.17 | Acidosis |
9211815 |
Acidosis alters the phosphorylation of Ser16 and Thr17 of phospholamban in rat cardiac muscle. |
therapeutic application
unassigned |
1
0 |
| 2.7.11.17 | Acidosis |
10699367 |
Caldesmon and heat shock protein 20 phosphorylation in nitroglycerin- and magnesium-induced relaxation of swine carotid artery. |
unassigned |
0 |
| 2.7.11.17 | Acidosis |
17222810 |
Ca2+/calmodulin-dependent protein kinase: a key component in the contractile recovery from acidosis. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 2.7.11.17 | Acidosis |
18723772 |
Increased intracellular Ca2+ and SR Ca2+ load contribute to arrhythmias after acidosis in rat heart. Role of Ca2+/calmodulin-dependent protein kinase II. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.7.11.17 | Adenocarcinoma |
9839502 |
The role of myofibroblasts at the tumor border of invasive colorectal adenocarcinomas. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 2.7.11.17 | Adenocarcinoma |
10674042 |
Differential expression of high molecular weight caldesmon in colorectal pericryptal fibroblasts and tumour stroma. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 2.7.11.17 | Adenocarcinoma |
16243820 |
Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. |
ongoing research
unassigned |
1
0 |
| 2.7.11.17 | Adenocarcinoma |
16892554 |
[Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis] |
ongoing research
unassigned |
2
0 |
| 2.7.11.17 | Adenocarcinoma |
22654108 |
A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
2
1
0 |
